Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemigliptin as add-on therapy to insulin with or without metformin in type 2 diabetes mellitus
TCTR20210225005Phase 3Completed
- Sponsor
- LG Chem Life Sciences
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemigliptin in type 2 diabetes mellitus (T2DM), sponsored by LG Chem Life Sciences. Started Oct 2016; status: completed.
02
Drugs
gemigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20210225005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210225005.